These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

588 related items for PubMed ID: 18223238

  • 21. Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses.
    Nagy B, Savli H, Molvarec A, Várkonyi T, Rigó B, Hupuczi P, Rigó J.
    Clin Chim Acta; 2008 Mar; 389(1-2):126-31. PubMed ID: 18167313
    [Abstract] [Full Text] [Related]

  • 22. A specific interleukin-1B haplotype correlates with high levels of IL1B mRNA in the lung and increased risk of non-small cell lung cancer.
    Landvik NE, Hart K, Skaug V, Stangeland LB, Haugen A, Zienolddiny S.
    Carcinogenesis; 2009 Jul; 30(7):1186-92. PubMed ID: 19461122
    [Abstract] [Full Text] [Related]

  • 23. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
    Park JY, Park JM, Jang JS, Choi JE, Kim KM, Cha SI, Kim CH, Kang YM, Lee WK, Kam S, Park RW, Kim IS, Lee JT, Jung TH.
    Hum Mol Genet; 2006 Jun 15; 15(12):1963-71. PubMed ID: 16687442
    [Abstract] [Full Text] [Related]

  • 24. Genotypes and haplotypes of matrix metalloproteinase 1, 3 and 12 genes and the risk of lung cancer.
    Su L, Zhou W, Asomaning K, Lin X, Wain JC, Lynch TJ, Liu G, Christiani DC.
    Carcinogenesis; 2006 May 15; 27(5):1024-9. PubMed ID: 16311244
    [Abstract] [Full Text] [Related]

  • 25. Vascular endothelial growth factor gene polymorphisms in ovarian cancer.
    Polterauer S, Grimm C, Mustea A, Concin N, Tanner B, Thiel F, Heinze G, Reinthaller A, Zeillinger R, Hefler LA.
    Gynecol Oncol; 2007 May 15; 105(2):385-9. PubMed ID: 17289129
    [Abstract] [Full Text] [Related]

  • 26. Association of VEGF genetic polymorphisms with prostate carcinoma risk and clinical outcome.
    Sfar S, Hassen E, Saad H, Mosbah F, Chouchane L.
    Cytokine; 2006 Jul 15; 35(1-2):21-8. PubMed ID: 16908180
    [Abstract] [Full Text] [Related]

  • 27. Polymorphisms in the vitamin D receptor gene and risk of lung cancer.
    Dogan I, Onen HI, Yurdakul AS, Konac E, Ozturk C, Varol A, Ekmekci A.
    Med Sci Monit; 2009 Aug 15; 15(8):BR232-42. PubMed ID: 19644412
    [Abstract] [Full Text] [Related]

  • 28. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
    Wang Y, Fang S, Wei L, Wang R, Jin X, Wen D, Li Y, Guo W, Wang N, Zhang J.
    Lung Cancer; 2005 Aug 15; 49(2):155-61. PubMed ID: 15949868
    [Abstract] [Full Text] [Related]

  • 29. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O, Hugli B, Ziegler A, Bigosch C, Bowers NL, Ratschiller D, Jermann M, Stahel RA, Heighway J, Betticher DC.
    Lung Cancer; 2006 Mar 15; 51(3):303-11. PubMed ID: 16406195
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
    Kim JG, Chae YS, Sohn SK, Cho YY, Moon JH, Park JY, Jeon SW, Lee IT, Choi GS, Jun SH.
    Clin Cancer Res; 2008 Jan 01; 14(1):62-6. PubMed ID: 18172253
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. VEGF polymorphisms in early cervical cancer susceptibility, angiogenesis, and survival.
    Kim YH, Kim MA, Park IA, Park WY, Kim JW, Kim SC, Park NH, Song YS, Kang SB.
    Gynecol Oncol; 2010 Nov 01; 119(2):232-6. PubMed ID: 20797778
    [Abstract] [Full Text] [Related]

  • 34. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
    Tseng RC, Hsieh FJ, Shih CM, Hsu HS, Chen CY, Wang YC.
    Cancer; 2009 Jul 01; 115(13):2939-48. PubMed ID: 19408343
    [Abstract] [Full Text] [Related]

  • 35. Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea.
    Bae SJ, Kim JW, Kang H, Hwang SG, Oh D, Kim NK.
    Anticancer Res; 2008 Jul 01; 28(2B):1271-6. PubMed ID: 18505065
    [Abstract] [Full Text] [Related]

  • 36. Polymorphisms of dopamine receptor/transporter genes and risk of non-small cell lung cancer.
    Campa D, Zienolddiny S, Lind H, Ryberg D, Skaug V, Canzian F, Haugen A.
    Lung Cancer; 2007 Apr 01; 56(1):17-23. PubMed ID: 17175058
    [Abstract] [Full Text] [Related]

  • 37. The SOD2 Val/Val genotype enhances the risk of nonsmall cell lung carcinoma by p53 and XRCC1 polymorphisms.
    Liu G, Zhou W, Park S, Wang LI, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC.
    Cancer; 2004 Dec 15; 101(12):2802-8. PubMed ID: 15534883
    [Abstract] [Full Text] [Related]

  • 38. O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer.
    Chae MH, Jang JS, Kang HG, Park JH, Park JM, Lee WK, Kam S, Lee EB, Son JW, Park JY.
    Mol Carcinog; 2006 Apr 15; 45(4):239-49. PubMed ID: 16385589
    [Abstract] [Full Text] [Related]

  • 39. Polymorphisms in EGFR and VEGF contribute to non-small-cell lung cancer survival in a Chinese population.
    Dong J, Dai J, Shu Y, Pan S, Xu L, Chen W, Wang Y, Jin G, Ma H, Zhang M, Hu Z, Shen H.
    Carcinogenesis; 2010 Jun 15; 31(6):1080-6. PubMed ID: 20400478
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.